Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

Clinical trial NCT07077512 · RECRUITING

Trial details

NCT number: NCT07077512
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large B Cell Diffuse Lymphoma Mantle Cell Lymphoma (MCL)Follicular Lymphoma ( FL)

Start date: 2025-09-15
Primary completion: 2027-01-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.